Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced the appointment of two Executive Leadership Team members. Terrance J.
Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced that one of its operating companies, Par Pharmaceutical, has begun shipping four dosage strengths (50 mg, …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced today that Suketu Upadhyay, Executive Vice President and Chief Financial Officer, is leaving the Company effective …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced new data to be presented evaluating the safety and efficacy of XIAFLEX®(collagenase clostridium histolyticum) (or CCH) …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) recently held an analyst event where management hosted a sell-side meeting at its Par facility, which …
Healthcare analysts chimed in on Bioline RX Ltd (NASDAQ:BLRX) and Endo International plc – Ordinary Shares (NASDAQ:ENDP), as both stocks are among the top performers today. The …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced that its Board of Directors has named Paul V. Campanelli President and Chief Executive Officer, …
Mizuho top analyst Irina Koffler assesses both short-term and long-term for Endo International plc – Ordinary Shares (NASDAQ:ENDP), believing there is every reason …
Morgan Stanley analyst David Risinger provides insight on shares of Endo International plc – Ordinary Shares (NASDAQ:ENDP), assessing a deeper look into its pipeline businesses …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) just released strong second-quarter results, posting revenue of $920.9 million and EPS of $0.
